Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels—The Framingham Heart Study
- 30 September 2009
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 206 (1) , 228-233
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Loci influencing lipid levels and coronary heart disease risk in 16 European population cohortsNature Genetics, 2008
- Genome-Wide Association Analysis of High-Density Lipoprotein Cholesterol in the Population-Based KORA Study Sheds New Light on Intergenic RegionsCirculation: Cardiovascular Genetics, 2008
- Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery diseaseExperimental Gerontology, 2008
- Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC StudyClinical Chemistry, 2008
- Genome-wide association studies of quantitative traits with related individuals: little (power) lost but much to be gainedEuropean Journal of Human Genetics, 2008
- The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reportsBMC Medical Genetics, 2007
- UDP-Glucuronosyltransferase 1A1 Gene Polymorphisms and Total Bilirubin Levels in an Ethnically Diverse Cohort of WomenDrug Metabolism and Disposition, 2007
- Human cell growth requires a functional cytoplasmic exosome, which is involved in various mRNA decay pathwaysRNA, 2007
- A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarctionJACC, 2004
- Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndromeHuman Genetics, 2004